Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.

  • Presentation

Personalized Persistence in Pediatric Dermatology: Skin Health, Common Conditions, and Treatment Journeys

Description

The speaker emphasizes “personalized persistence” in pediatric dermatology, arguing that meaningful change depends on trust, education, and repeated counseling rather than a single short visit. Core skin-health messages include sun protection, gentle hydrating skincare, avoiding irritants and unnecessary fragrances, and promoting nutrition and healthy living. The talk reviews common pediatric conditions and practical treatments, focusing on molluscum contagiosum, verruca, and atopic dermatitis. For molluscum, the speaker notes that pediatric evidence is limited because trials are hard to conduct, but highlights FDA-approved options such as cantharidin and berdazimer, along with off-label approaches like tretinoin, cimetidine/famotidine, potassium hydroxide, salicylic acid, and zinc supplementation. For warts, salicylic acid is the main FDA-approved option, while other destructive or off-label therapies may be used selectively. The atopic dermatitis discussion frames the disease as a complex skin-barrier and immune disorder influenced by irritants, allergens, microbes, and comorbid atopy; treatment should restore the barrier, manage infection, and use steroids or newer non-steroidal systemic and topical therapies when appropriate. The speaker also stresses practical issues such as choosing syringes vs auto-injectors, distraction techniques for injections, and tailoring plans to what families will accept. Overall, the message is that pediatric dermatology is a journey of individualized, persistent care that improves skin disease outcomes and family trust.

View more

Conclusions

  • Pediatric dermatology care works best when it is built on personalized persistence, trust, and repeated counseling rather than a one-time visit.
  • For children, the foundations of skin health are sun protection, gentle hydrating skincare, and good nutrition.
  • Because pediatric dermatology has limited FDA-approved options, off-label and repurposed therapies remain important, especially for common conditions like molluscum contagiosum and warts.
  • Molluscum contagiosum can often be managed with topical, in-office, or home-based treatments, and newer FDA-approved therapies expand practical options for families.
  • Tretinoin, cimetidine, famotidine, and zinc supplementation may be useful adjuncts for molluscum and verruca in selected children, even though much of the evidence remains limited.
  • Waiting for molluscum to resolve on its own may increase parental anxiety, so active treatment can be justified when families want faster control.
  • Atopic dermatitis is a combined barrier-and-immune disorder driven by both inside-out and outside-in processes.
  • Atopic dermatitis commonly coexists with asthma, allergic rhinitis, food allergy, eosinophilic esophagitis, skin infections, and other inflammatory skin conditions.
  • Restoring the skin barrier, clearing infection, and reducing inflammation are central goals in treating pediatric atopic dermatitis.
  • Modern non-steroidal therapies and biologics are expanding the ability to control pediatric atopic dermatitis and may improve both severity and visible discoloration.
  • Families are often most motivated by visible changes like hyperpigmentation or dispigmentation, so treatment plans should address what matters most to them.
  • Early and effective treatment of atopic dermatitis may reduce later risk of food allergy and other allergic disease.
  • Injection therapies for young children are more successful when clinicians use pain-reduction strategies, caregiver coaching, and calming physical support such as a bear hug.
  • Recognizing and treating the full set of skin problems at once—eczema, infection, contact irritation, and related comorbidities—leads to better real-world pediatric outcomes.
  • Ulrych et al. Molluscum contagiosum: a comprehensive review of treatment modalities. Wiad Lek. 2025;78(7):1418-1425. doi: 10.36740/WLek/206905. PMID: 40847879.#10.36740/WLek/206905
  • A. Vehapoglu in Nutrition 91–92 (2021). Fig. 2. (A, B) 15-mo-old boy displaying multiple molluscum contagiosum lesions, mostly on the trunk and legs, and (C) complete lesion resolution after 8 wk of treatment.
  • Leung D YM and Guttman-Yassky E, JACI 2014.
  • Davis DMR et al. (graphic layout adapted from).
  • Risk Factors for the Development of Food Allergy in Infants and Children: A Systematic Review and Meta-Analysis. JAMA Pediatrics.